Titan Biotech Limited (TITANBIO.BO)
INR 781.0
(1.07%)
INR 781.0
(1.07%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 199.76 Million | 211.78 Million | 228.59 Million | 190.82 Million | 61.16 Million | 54.66 Million |
| Net Income | 248.53 Million | 281.16 Million | 381.98 Million | 427.05 Million | 104.04 Million | 55.44 Million |
| Depreciation & Amortization | 33.3 Million | 26 Million | 25.38 Million | 22.17 Million | 18 Million | 17.11 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -73.68 Million | -31.31 Million | -106.18 Million | -169 Million | -64.99 Million | -30.92 Million |
| Other non-cash items | 131.9 Million | -64.07 Million | -72.59 Million | -89.4 Million | 4.11 Million | 13.03 Million |
| Investing Cash Flow | -203.03 Million | -207.25 Million | -187.85 Million | -48.64 Million | -22.1 Million | -41.08 Million |
| Investments in PPE | -89.98 Million | -204.59 Million | -187.85 Million | -48.64 Million | -54.51 Million | -44.47 Million |
| Acquisitions | 2.91 Million | - | - | - | - | - |
| Investment purchases | -115.97 Million | -2.65 Million | -27.56 Million | -1.59 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | 1.36 Million | 3.43 Million |
| Other Investing Activities | 2.91 Million | - | 27.56 Million | 1.59 Million | 31.04 Million | -39.61 Thousand |
| Financing Cash Flow | -16.96 Million | -24.03 Million | 60.81 Million | -105.99 Million | -39.48 Million | -2.2 Million |
| Debt repayment | -1.72 Million | -7.82 Million | -17.36 Million | -97.53 Million | -16.12 Million | -21.3 Million |
| Dividends payments | -14.87 Million | -12.39 Million | -12.39 Million | -8.26 Million | - | - |
| Common Stock Repurchased | - | - | -22.29 Million | - | - | - |
| Common Stock Issuance | - | - | 56.43 Million | - | - | 42 Million |
| Other Financing Activities | -15.51 Million | -3.81 Million | 56.43 Million | -191.74 Thousand | -23.35 Million | -22.89 Million |
| Accounts receivables | 35.28 Million | -49.39 Million | 20.32 Million | -136.92 Million | -24.37 Million | -4.16 Million |
| Accounts payables | -14.95 Million | 32.98 Million | 24.88 Million | 15.12 Million | 27.81 Million | 8.73 Million |
| Inventory | -94.01 Million | -14.89 Million | -97.56 Million | -45.61 Million | -68.42 Million | -35.49 Million |
| Other working capital | -14.95 Million | 1000.00 | -53.82 Million | -1.59 Million | 0.93 | 0.33 |
| Cash at beginning of period | 48.63 Million | 68.13 Million | 54.5 Million | 18.32 Million | 18.74 Million | 7.36 Million |
| Cash at end of period | 28.4 Million | 48.63 Million | 156.06 Million | 54.5 Million | 18.32 Million | 18.74 Million |
| Capital Expenditure | -89.98 Million | -204.59 Million | -187.85 Million | -48.64 Million | -54.51 Million | -44.47 Million |
| Effect of forex changes on cash | - | - | - | - | 0.75 | 0.21 |
| Net cash flow / Change in cash | -20.23 Million | -19.5 Million | 101.56 Million | 36.17 Million | -421.69 Thousand | 11.38 Million |
| Free Cash Flow | 109.77 Million | 7.18 Million | 40.74 Million | 142.17 Million | 6.64 Million | 10.19 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 248.53 Million | 71.74 Million | 65.21 Million | 61.6 Million | 49.51 Million | 281.16 Million |
| Depreciation & Amortization | 33.3 Million | 8.34 Million | 8.59 Million | 7.96 Million | 7.1 Million | 26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -73.68 Million | - | - | - | - | -31.31 Million |
| Other non-cash items | 131.9 Million | -63.39 Million | -8.59 Million | -7.96 Million | -7.1 Million | -64.07 Million |
| Investing Cash Flow | -203.03 Million | - | - | - | - | -207.25 Million |
| Investments in PPE | -89.98 Million | - | - | - | - | -204.59 Million |
| Acquisitions | 2.91 Million | - | - | - | - | - |
| Investment purchases | -115.97 Million | - | - | - | - | -2.65 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -16.96 Million | - | - | - | - | -24.03 Million |
| Debt repayment | -1.72 Million | - | - | - | - | -7.82 Million |
| Dividends payments | -14.87 Million | - | - | - | - | -12.39 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -3.81 Million |
| Accounts receivables | 35.28 Million | - | - | - | - | -49.39 Million |
| Accounts payables | -14.95 Million | - | - | - | - | 32.98 Million |
| Inventory | -94.01 Million | - | - | - | - | -14.89 Million |
| Other working capital | - | - | - | - | - | 1000.00 |
| Cash at beginning of period | 48.63 Million | 45.63 Million | -19.57 Million | 48.63 Million | -875 Thousand | 68.13 Million |
| Cash at end of period | 28.4 Million | 62.33 Million | 45.63 Million | 61.6 Million | 48.63 Million | 48.63 Million |
| Capital Expenditure | -89.98 Million | - | - | - | - | -204.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -20.23 Million | 16.69 Million | 65.21 Million | 12.96 Million | 49.51 Million | -19.5 Million |
| Free Cash Flow | 109.77 Million | 16.69 Million | 65.21 Million | 61.6 Million | 49.51 Million | 7.18 Million |
PML
002669
WFC-PL
2605
CNK
ACVA